SCHEMBL21551285

SCHEMBL21551285

COC(=O)c1cc(Oc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)nc2)nc(Cl)n1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 2/20 0.49
▸ PGK1 P00558 1/20 0.46
▸ RET P07949 8/20 0.44
▸ CKS1B P61024 2/20 0.43
▸ SKP1 P63208 2/20 0.43
▸ SKP2 Q13309 2/20 0.43
▸ DDB1 Q16531 1/20 0.43
▸ CRBN Q96SW2 1/20 0.43
▸ MAP4K4 O95819 1/20 0.42
▸ ADK P55263 1/20 0.42
▸ WNT3A P56704 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ SUV39H2 Q9H5I1 1/20 0.40
▸ TBK1 Q9UHD2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30931776 1.00 GPR119 (0.49) GPR119PGK1RETCKS1BSKP1
SCHEMBL21550824 0.88 GPR119 (0.45) GPR119PGK1RETCKS1BSKP1
SCHEMBL21551211 0.86 GPR119 (0.49) GPR119PGK1RETCKS1BSKP1
SCHEMBL30931789 0.86 GPR119 (0.49) GPR119PGK1RETCKS1BSKP1
SCHEMBL29890823 0.86 GPR119 (0.49) GPR119PGK1RETCKS1BSKP1
SCHEMBL26077350 0.85 ALDH1A1 (0.45) TSHRKMT2A
SCHEMBL3711381 0.81 CKS1B (0.46) GPR119PGK1CKS1BSKP1SKP2
SCHEMBL21553728 0.81 PGK1 (0.47) GPR119PGK1RETCKS1BSKP1
SCHEMBL30931809 0.81 FURIN (0.48) GPR119PGK1RETCKS1BSKP1
SCHEMBL21551215 0.81 FURIN (0.48) GPR119PGK1RETCKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112384509-B Furin inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2024-04-30 — — CN disclosed
EP-3790871-B1 FURIN INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2024-01-24 — — EP disclosed
EP-3790871-B1 FURIN INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2024-01-24 — — EP disclosed
US-11773078-B2 Furin inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-10-03 — — US disclosed
US-20220315556-A1 FURIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2022-10-06 — — US disclosed
EP-3790871-A1 FURIN INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2021-03-17 — — EP disclosed
CN-112384509-A Furin inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2021-02-19 — — CN disclosed
WO-2019215341-A1 FURIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-11-14 — — WO disclosed
WO-2019215341-A1 FURIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-11-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315556-A1 FURIN INHIBITORS FURIN, TGFB1, PCSK7 GPR119 2318/4885PGK1 2564/4885RET 1057/4885
US-11773078-B2 Furin inhibitors FURIN, TGFB1, PCSK7 GPR119 2318/4885PGK1 2564/4885RET 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback